Heart Arrest Clinical Trial
Official title:
Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia
Myocardial protection is a fundamental element for the safety of patients when performing
cardiac surgery. For this purpose, cardioplegia were rapidly established in clinical practice
to protect the myocardium when performing aortic clamp.
Cardioplegia are procedures to stop the contraction of myocardium. It is usually achieved
with the use of chemicals ( cardioplegic solutions) or cold temperature (such as chilled
perfusate). The composition of the cardioplegic solutions and their method of administration
continuously changed over the years.
At the present date, cold blood cardioplegias are performed in the investigator's center. The
investigators regularly use two modes of administration: either by an antegrade path
(injection in the coronary arteries), or a retrograde one (injection in the venous system).
At present, there are no elements supporting the superiority or inferiority of one path
compared to another. The difficulty lies within a clear estimation of the contractility state
of the ventricular cardiac muscle.
Technological developments in recent years provided a solution to this problem. The analysis
of the pressure/volume curves generated by a ventricle allows an accurate quantification of
the myocardial contractility. This requires the use of conductance catheters to accurately
measure the ventricular volume and the ventricular pressure. The absolute ventricular
contractility is then deduced with the help of a software.
The investigators intend to use this pressure-volume loops, obtained with conductance
catheters, to compare the contractility of the right heart ventricle after antegrade vs
retrograde cardioplegia.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04078815 -
End-of-life Practices in 2019 vs. 2014
|
||
| Completed |
NCT02486211 -
Amantadine to Speed Awakening After Cardiac Arrest
|
Phase 2 | |
| Recruiting |
NCT02326506 -
Evaluation of Drainable Volume Measurements During VA-ELS
|
N/A | |
| Completed |
NCT00139542 -
AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named "One Shock Per Minute"
|
Phase 3 | |
| Completed |
NCT00004560 -
Public Access Defibrillation (PAD) Community Trial
|
Phase 3 | |
| Completed |
NCT00000502 -
Evaluation of SC-V Versus Conventional CPR
|
Phase 3 | |
| Completed |
NCT03640949 -
Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
|
Phase 2/Phase 3 | |
| Completed |
NCT03310450 -
Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels
|
||
| Not yet recruiting |
NCT06048796 -
Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest
|
N/A | |
| Completed |
NCT02733146 -
Histones and Free-plasma DNA After Cardiac Arrest
|
N/A | |
| Withdrawn |
NCT01082991 -
Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest
|
Phase 0 | |
| Terminated |
NCT00189423 -
ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest
|
N/A | |
| Completed |
NCT00172354 -
Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest
|
N/A | |
| Completed |
NCT02858583 -
SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
|
N/A | |
| Completed |
NCT03664557 -
Feasibility of REBOA in Refractory Cardiac Arrest
|
N/A | |
| Completed |
NCT01968148 -
Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest
|
N/A | |
| Completed |
NCT00392639 -
Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study)
|
Phase 4 | |
| Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
| Recruiting |
NCT05321459 -
Predictive Outcome in Comatose Patients
|
||
| Completed |
NCT02780050 -
Influence of Core Muscles Activation Using Physical Fitness on the Performance of Chest Compression
|
N/A |